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Potential Influence of Advance Care Planning and Palliative Care
Consultation on ICU Costs for Patients With Chronic and Serious Illness.
Abstract
OBJECTIVES: To estimate the potential ICU-related cost savings if in-hospital advance care planning and
ICU-based palliative care consultation became standard of care for patients with chronic and serious illness.
DESIGN AND SETTING: Decision analysis using literature estimates and inpatient administrative data from
Premier.
PATIENTS: Patients with chronic, life-limiting illness admitted to a hospital within the Premier network.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Using Premier data (2008-2012), ICU resource utilization and
costs were tracked over a 1-year time horizon for 2,097,563 patients with chronic life-limiting illness. Using a
Markov microsimulation model, we explored the potential cost savings from the hospital system perspective
under a variety of scenarios by varying the interventions' efficacies and availabilities. Of 2,097,563 patients,
657,825 (31%) used the ICU during the 1-year time horizon; mean ICU spending per patient was 11.3k (SD,
17.6k). In the base-case analysis, if in-hospital advance care planning and ICU-based palliative care
consultation were systematically provided, we estimated a mean reduction in ICU costs of 2.8k (SD, 14.5k)
per patient and an ICU cost saving of 25%. Among the simulated patients who used the ICU, the receipt of
both interventions could have resulted in ICU cost savings of 1.9 billion, representing a 6% reduction in total
hospital costs for these patients.
CONCLUSIONS: In-hospital advance care planning and palliative care consultation have the potential to
result in significant cost savings. Studies are needed to confirm these findings, but our results provide guidance
for hospitals and policymakers.
Keywords
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Support Techniques, Female, Hospital Costs, Humans, Intensive Care Units, Length of Stay, Male, Markov
Chains, Middle Aged, Palliative Care, Patient Admission
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Abstract
 Objective—To estimate the potential ICU-related cost-savings if in-hospital advance care 
planning and ICU-based palliative care consultation became standard of care for patients with 
chronic and serious illness.
 Design and Setting—Decision analysis using literature estimates and inpatient 
administrative data from Premier, Inc.
 Patients—Patients with chronic, life-limiting illness admitted to a hospital within the Premier 
network.
 Methods—Using Premier data (2008-2012), ICU resource utilization and costs were tracked 
over a 1-year time horizon for 2,097,563 patients with chronic life-limiting illness. Using a 
Markov microsimulation model, we explored the potential cost-savings from the hospital system 
perspective under a variety of scenarios by varying the interventions' efficacies and availabilities.
 Main Results—Of 2,097,563 patients, 657, 825 (31%) utilized the ICU during the 1-year time 
horizon; mean ICU spending per patient was 11.3k (SD 17.6k). In the base-case analysis, if in-
hospital advance care planning and ICU-based palliative care consultation were systematically 
provided, we estimated a mean reduction in ICU costs of 2.8k (SD 14.5k) per patient and an ICU 
cost-savings of 25%. Among the simulated patients who utilized the ICU, the receipt of both 
interventions could have resulted in ICU cost savings of 1.9 billion, representing a 6% reduction in 
total hospital costs for these patients.
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 Conclusions—In-hospital advance care planning and palliative care consultation have the 
potential to result in significant cost-savings. Studies are needed to confirm these findings, but our 
results provide guidance for hospitals and policy-makers.
Keywords
End-of-life care; palliative care; ICU utilization; economics
 Introduction
Caring for critically ill patients with a high risk of death in the intensive care unit (ICU) 
involves complex decision-making on the part of both providers and families. 
Communication strategies aimed at facilitating decision-making processes for patients and 
surrogate decision-makers have shown an improvement in patient and family emotional 
outcomes (1). The goal of interventions that target increasing the frequency and quality of 
communication about end-of-life care is to ensure that care remains patient-centered and is 
respectful of individual preferences and values (1-3). These interventions include advance 
care planning (ACP) and both “primary” and “specialty” palliative care (4). Primary 
palliative care is care provided by all clinicians caring for patients with serious illness while 
specialty palliative care is provided by palliative care specialists, including physicians, 
nurses, social works and others (4). For the purpose of this study, we consider interventions 
such as ethics consultation and routine ICU family conferences to be a form of primary 
palliative care because they are designed, in part, to improve communication between 
clinicians and family members. We use the term “palliative care” inclusively to refer to both 
“primary” and “specialty” palliative care.
In this context, there is evidence to suggest that providing patient-centered care for patients 
with chronic and serious illness can lead to a reduction in intensity of care near the end-of-
life. For example, there is evidence that ACP early during an acute care hospitalization can 
reduce ICU admissions (5, 6) and that proactive early palliative care consultation in the ICU 
can reduce the length of stay (LOS) for patients who die in the ICU (1, 7-13). However, 
despite this evidence, eliciting and implementing patients' values and preferences for end-of-
life care in the ICU has proven difficult in actual practice(14, 15).
To help payers and policymakers guide resource allocation for primary and specialty 
palliative care programs, evidence from economic evaluations is important (16, 17). The 
degree to which cost-savings could result from patient-centered care at the end-of-life 
remains unknown and continues to be a topic of debate (18, 19). The objective of this study 
is to estimate the potential ICU cost-savings, from a hospital system perspective over a 1-
year time horizon, that may result if in-hospital ACP and ICU-based palliative care 
interventions for patients with serious life-limiting illness were standard of care. We chose to 
focus on in-hospital ACP and palliative care interventions because these interventions have 
the most compelling data supporting cost reductions.
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 Methods
 Data and eligibility criteria
Data are from patients seen in hospitals participating in the Premier network from 
2008-2012. Premier is a national alliance of over 2,000 community-based hospitals that 
operates a detailed clinical and financial database. Hospitals with varying structures and 
models of care electively participate in the Premier alliance. Patients can be tracked with a 
unique patient identifier throughout multiple inpatient admissions within participating 
hospitals.
We identified a cohort of adult patients with chronic life-limiting illness considered to be at 
high risk of death using criteria that have been previously identified (10, 13, 20, 21) (Table 
1). We excluded patients with the DRG (Diagnosis-related group) upcode associated with 
palliative care (V66.7; 4.3% of patients) and assumed the remaining patients did not receive 
palliative care interventions. The first hospital admission during which a patient met one of 
the qualifying criteria was considered the index event and we examined patients' ICU and 
hospital resource utilization over the following 12 months.
 Decision analytic model
Decision analysis is an approach for assessing the relative value of different decision options 
when data from randomized trials are limited. In this form of analysis, a model is built that 
simulates patients' decisions and outcomes. This Markov microsimulation model starts with 
initial or “default” values that replicate the patterns of ICU utilization and costs documented 
in Premier data. Using estimates of the effectiveness of ACP and palliative care interventions 
from the literature, we then alter the parameters of the model to simulate ICU utilization, 
and their corresponding costs, relevant to these interventions. For example, we were able to 
simulate patient trajectories if ACP were standard of care by decreasing the probability of 
using the ICU during a given hospitalization from the observed level in the Premier data. We 
also simulate trajectories if routine palliative care consultation in the ICU were standard of 
care for these patients by decreasing ICU LOS from that observed in the Premier data. In 
this type of stochastic model, patient care trajectories only depend on the patient's current 
state (hospital, ICU, death), and not the entire sequence of care that preceded it. We included 
one deviation from the Markov model assumptions—only the first three times each 
intervention was offered were considered potentially effective. Refer to Section A in the 
online supplement for additional details regarding model specifics and Section F for more 
details on modeling limitations.
Figure 1 shows the basic flow of patient care during the 12 months following index 
hospitalization. After becoming eligible for entry in our cohort, patients experienced some 
combination of ICU admissions, hospital readmissions, and deaths. We estimated the 
fraction of patients in each trajectory using empirical proportions.
For each distinct patient trajectory, we required estimates of the distributions of ICU LOS, 
ICU costs, and ICU costs relative to acute care costs. We used the actual Premier data to 
estimate distributions of costs and to estimate the care trajectories under standard care. 
Flexible parametric distributions were used to estimate distributions of costs and LOS, while 
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empirical proportions were used to estimate care trajectories. The size of the Premier sample 
allowed us to estimate relevant quantities with a high degree of precision. Estimates of the 
proportion of patients in each distinct patient trajectory are displayed in Tables E1 and E2, 
along with estimates of the distribution of ICU LOS (Table E3), marginal costs savings of 
ICU days relative to acute care floor days (Table E4), and total ICU costs (Section E). We 
show a comparison of these estimates of distributions to the actual data observed in Premier 
in Figures E1-E3.
 Effect of interventions
Our primary interest was assessing cost savings if ACP and/or palliative care consultation 
were routine practice. Using our model for patient flow based on the observed Premier data, 
we simulated the effect of these interventions and examined cost savings across a range of 
efficacies for both in-hospital ACP and ICU-based palliative care consultation. In our base-
case model for the intervention arm, we assumed that all eligible patients received ACP or 
palliative care consultation (100% penetration). The efficacy of these interventions for the 
base-case model was estimated from a systematic review of available published data (22). 
In-hospital ACP was estimated to reduce ICU admissions by 37% for all patients. Each 
patient was randomly assigned a palliative care consultation effectiveness assuming a 
reduction in ICU LOS from a normal distribution with the mean of 26% (SD: 23%). 
Recognizing that the literature from which we obtained our estimates is limited, in addition 
to our base-case model, we examined cost savings across a range of penetrations and 
intervention efficacies (zero effect to 25% more effective).
We simulated the effect of ACP by “offering” the intervention to eligible patients at the time 
of index hospital admission (56.5% of patients were admitted directly to the ICU and 
considered ineligible to receive in-hospital ACP). For patients offered ACP, in the base-case, 
37% of patients were randomly selected to have a reduced probability of a subsequent ICU 
admission. If a patient is readmitted to the hospital or transferred back to acute care after an 
ICU admission, they are again eligible to receive in-hospital ACP for up to 3 acute care 
admissions. After the third admission, we assume ACP has no additional effect. Each time 
an ICU admission is avoided due to an ACP intervention, we assume that LOS is constant, 
only the location of care changes from the ICU to acute care and we calculate the cost 
savings as the marginal difference between ICU days and acute care days for that patient.
We simulated the effect of palliative care consultation by “offering” the intervention to 
patients at the time of ICU admission. Consider a patient who under usual care is admitted to 
the ICU and has a LOS of 10 days. After receiving a palliative care consultation at the base-
case 26% efficacy, this patient's LOS would be reduced to 7.4 days and we would calculate 
cost savings due to palliative care consultation as the marginal difference between 2.6 days 
in the ICU versus acute care for a patient who survived their ICU stay. For the patients who 
die in the ICU, the cost saving is calculated as the total ICU costs for the reduction of days 
in the ICU. We again assumed that the randomly assigned effect of palliative care 
consultation (based on normal distribution with mean 26% (SD 23%)) would be the same on 
the second and third ICU admissions and after the third ICU admission there would be no 
effect. In accordance with Markov assumptions, each subsequent hospitalization and receipt 
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of intervention was independent of previous hospitalizations and ICU use. Additionally, 
based on limited literature, we made the assumption that the intervention was only 1/3 as 
effective in reducing LOS for patients who survived their ICU stay, compared to patients 
who died in the ICU (11, 13).
 Sensitivity Analyses
We explored cost savings due to ACP and palliative care consultation across a range of 
efficacies in survivors. In addition, since previous studies suggest that the primary 
mechanism for reducing ICU LOS and ICU costs is likely earlier decisions to withdraw life-
sustaining treatments (7, 8, 12, 23), we hypothesized that selecting a more targeted 
population with a higher mortality may have a significant impact on overall cost-savings by 
decreasing the number of ICU days. To explore this, we performed a sensitivity analysis 
varying the probability of death during any hospital admission.
Costs in all analyses were adjusted for inflation and reported in 2013 U.S $. All costs 
represent actual costs, not charges. The models were constructed using STATA statistical 
software, version 12.0 (StataCorp., College Station, TX) and results were summarized using 
R 3.0.0 (www.cran.r-project.org). Results are based on three million simulated patients; this 
sample size gave us estimates of cost savings with negligible variation due to Monte Carlo 
sampling. The research use of non-identifiable, coded Premier data was conducted in 
compliance with University of Washington policy and did not require IRB review or 
approval.
 Results
 Characteristics of patient sample
We identified 2,097,563 patients who met one or more of our inclusion criteria between 
1/1/2008 and 12/31/2011 (Table 1). Forty-two percent of patients were older than 80; 28% of 
patients were ≥ 65 years old with end-stage renal disease and roughly 18% had a previous 
stroke or COPD requiring prior hospitalization. Sixty-seven percent of patients were 
admitted through the emergency department. The mean age was 73 years (SD 14); 47.5% of 
the cohort was male, and 68% were white. Overall, 6.2% of patients had a recorded in-
hospital death within a year of index hospitalization (Table 2).
 ICU utilization and costs
Of patients meeting our inclusion criteria for chronic life-limiting illness or advanced age 
with acute illness, 657, 825 (31%) utilized the ICU during the 1-year time horizon; mean 
ICU spending per patient was 11.3k (SD 17.6k). Mean number of ICU admissions per 
patient was 1 (SD 1). Mean number of days spent in the ICU during the 1-year time horizon 
was 7 (SD 10). Of patients utilizing the ICU, 11.5% died in a Premier hospital - 9.4% in 
acute care, 2.1% in the ICU.
Overall, 23.8% of patients had an ICU admission during their index hospitalization; 2.5% of 
these patients died in their first ICU stay, while 97.5% were discharged to acute care. Of 
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those discharged to acute care, 86.1% were discharged from the hospital and 13.9% went 
back to the ICU during this first hospital admission.
 Simulation results
Figure 2 displays the results of our analysis varying the efficacy of the interventions. At 
base-case efficacy, if both ACP and palliative care consultation were systemically provided 
to all eligible patients, on average $2.8k per patient could be saved; this represents an ICU 
cost-savings of 25% (Panel A). If only in-hospital ACP were offered, these patients would 
save on average $1.8k (cost savings 16%). If only ICU-based palliative care consultation 
were offered, these patients would save an average of $1.3k cost savings (12%). At our most 
optimistic efficacy projections (46.3% ACP efficacy, 32.5% palliative care efficacy) total 
cost savings were about $3.4k (30%). Even if ACP only reduced ICU admissions by 9.3% 
and palliative care consultation reduced ICU LOS by 6.5%, we still estimate a cost savings 
of $800 per patient (7%). The cost savings over the entire sample of patients meeting 
inclusion criteria is shown in Panel B.
We also report results of varying the penetration at random of ACP and palliative care 
consultation (number of eligible patients who actually receive the intervention) in 
Supplemental Figure E4. Although these results are equivalent to varying the effectiveness 
of the intervention, this interpretation may be important from a system's perspective.
Among patients who utilized the ICU under usual care, the receipt of both interventions 
would have resulted in ICU cost savings of $1.9 billion over 1 year, representing a 6% 
reduction in total inpatient costs ($33.7 billion) for these patients. These interventions could 
theoretically cut total ICU costs ($16.8 billion) by an estimated 11% per year for the 
hospitals participating in the Premier system.
 Sensitivity Analyses
In our base-case analysis, the effectiveness of the palliative care consultation intervention 
was 1/3 as effective in survivors as in patients who die. Cost savings when this differential 
efficacy is varied are displayed in Figure 3. For interventions including both in-hospital ACP 
and ICU-based palliative care consultations, cost-savings for patients utilizing the ICU under 
usual care ranged from $2.1k to 4.3k (Panel A). Similar results for all patients meeting 
inclusion criteria are shown in Panel B.
We also varied the 1-year mortality of the underlying target population to assess its influence 
on cost-savings. If the mortality was ½ of what was observed in our Premier sample, the 
savings were $2.76k per patient utilizing the ICU; for mortality 3× higher, the savings were 
$2.92k per patient.
 Discussion
Our findings demonstrated four key findings: (1) based on available estimates of 
intervention effects, a savings of $2800 per patient, (representing 11% of all ICU costs and 
25% of ICU costs for eligible patients utilizing the ICU), can theoretically be achieved 
through systematic offering of in-hospital ACP and ICU-based palliative care consultation; 
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(2) varying the effectiveness of these interventions gives us a range of savings from $3.4k to 
$800 per patient; (3) as a single intervention, in-hospital ACP is more effective in reducing 
overall costs when compared to palliative care consultation in the ICU, although both appear 
to reduce costs; and (4) varying the mortality of the target population did not lead to a 
significant decrease in overall savings but did lead to modest variation in savings on a per-
treated patient basis. These findings suggest that, among hospital-based interventions, ACP 
and palliative care consultation have the potential to improve the quality of care for patients 
with life-limiting illness while simultaneously reducing high intensity care and associated 
healthcare costs. Our findings also provide estimates of the potential magnitude of these 
costs savings. Our results are consistent with previous findings that preventing an ICU 
admission all together is more effective in saving costs than reducing the ICU LOS (24), 
suggesting that ACP early in the course of a hospitalization has the most potential for cost-
savings. While the importance of this magnitude of cost-savings to healthcare policy experts 
is a subjective assessment, these data can help to answer whether or not in-hospital ACP and 
ICU-based palliative care interventions can pay for themselves through hospital cost-
savings.
The United States spends greater than $80 billion on critical illness per year, representing 
3% of total health care spending (25). If the greater than 2,000 hospitals that opt to 
participate in the Premier network are representative, our results can be extrapolated to 
potential national savings of $8.8 billion (11%) in ICU cost-savings system-wide over 1 
year. While this may be modest savings compared to the nearly $3 trillion spent on 
healthcare annually in this country (26), it is important to recognize that no single 
intervention is going to solve the healthcare spending crisis. Interventions that improve the 
quality of care, such as ACP and palliative care consultation, while reducing unwanted 
expensive medical care, should receive increased attention. These interventions seek to 
individualize care, matching medical care to treatment preferences of informed patients and 
their families. Prior studies have demonstrated mismatches between patient preferences and 
care delivered (27); these interventions aim to close that gap and have demonstrated 
improved quality of life and mood (28).
We emphasize that the primary rationale for these interventions is to improve quality of care 
and improve patient and family outcomes. However, recognizing that hospital and payer 
resources are limited, decisions regarding where and how to allocate resources can be 
influenced by economic consequences. Estimating the cost-savings for ACP and palliative 
care interventions has been challenging for a variety of reasons, including: 1) estimates of 
intervention effects on utilization from the literature have wide variation with significant 
uncertainty; 2) extremely large sample sizes are needed to accurately assess costs; and 3) 
retrospective decedent analyses may be confounded by indication bias and limited in that we 
cannot accurately predict who will die (29). We attempted to address these challenges by 
using decision analysis to model cost-savings from the hospital perspective if these 
interventions were standard of care. In developing this model, we addressed many of the 
concerns regarding economic evaluations pertaining to reducing ICU costs (17, 19). First, 
we performed a non-decedent analysis by identifying a broad cohort with serious illness or 
advanced age with acute illness and tracking utilization for 1 year after. Second, we applied 
differential effects for survivors and decedents, recognizing that the main mechanism of 
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action for reducing costs with palliative care consultation in the ICU is likely earlier 
withdrawal of non-beneficial or unwanted life-sustaining therapies. In addition, we used 
actual costs, rather than charges, and accounted for the marginal savings of reducing ICU 
LOS and replacing it with acute care days for ICU survivors. We also accounted for 
variability in ICU costs by day of stay and selected a national sample to avoid the limitation 
of regional variation in ICU utilization (30).
 Limitations
We acknowledge that our approach has several limitations. First, we recognize that the 
systematic review from which we based the magnitude of intervention effects for the base-
case is limited by the quality and number of original studies. Furthermore, we acknowledge 
that estimates obtained from observational studies may introduce bias if patients who agree 
to these interventions are more likely to limit life-sustaining interventions. This, however, is 
a reflection of the current state of the literature. For this reason, we conducted multiple 
sensitivity analyses varying the effect of the interventions, including the effect on survivors, 
to provide a range of potential cost-savings. Second, the estimates of cost-savings do not 
account for the costs of implementing ACP or palliative care programs; to our knowledge, 
robust estimates for these costs are not available. The range of cost-savings we provided, 
however, can help guide providers, payers and policymakers regarding the margin of savings 
that are possible given the costs of implementing a robust palliative care program in a 
particular hospital. Third, in the Premier database, we were unable to identify all patients 
who may have had a palliative care consultation or ACP and therefore may be 
underestimating the potential cost savings by assuming all patients received “usual care” 
without these interventions. Furthermore, we were unable to determine if a patient died at 
home or in a hospital that is not part of the Premier network; thus, our mortality may be 
lower than expected based on our inclusion criteria. The potential savings we report are 
therefore likely to be conservative estimates. Fourth, our model only addresses in-hospital 
ACP and ICU-based palliative care consultation and may under-estimate the potential 
benefits of outpatient or community-based programs. We chose to focus on in-hospital ACP 
and palliative care interventions because these interventions have the most compelling data 
supporting cost reductions, although application of these interventions in the outpatient or 
community setting could potentially have a significantly greater impact and should be the 
focus of future studies. Fifth, the derivation dataset is based on patient trajectories, outcomes 
and costs during the sampling period. Medical care, disease-specific life expectancy and 
healthcare costs change over time and thus the accuracy of these microsimulation results 
may decrease over time. Sixth, we recognize that our assumption about the effectiveness of 
interventions over time may bias cost estimates upward or downward. Our sensitivity 
analysis around the effectiveness of the ACP and palliative care interventions overall can 
give an estimate of the cost savings if the interventions became progressively more or less 
effective. (See Section F in the online supplement for additional details.) Lastly, we designed 
this model for a 1-year time horizon. Future research will require extending the time-horizon 
to understand the true impact of fixed and variable costs. One argument for lack of savings 
in the ICU is the high proportion of fixed costs that are not saved when bed occupancy is 
reduced; however, over a long enough time horizon, fixed costs can become variable costs 
by reducing growth in ICU-bed and ICU-staffing needs (19).
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Establishing the true efficacy of these interventions will require large randomized trials and 
other experimental designs, aimed at developing personalized treatment goals that maximize 
quality of life and care, while minimizing costs. In the meantime, our modeling of the 
potential cost-savings from in-hospital ACP and palliative care consultation can help inform 
providers, payers, hospital administrators and policymakers about the utility of investing 
resources in developing these interventions to improve the quality of end-of-life care.
 Conclusions
Advance care planning and palliative care consultation have been associated with improved 
quality of care for patients with serious and life-limiting illness. The results of our model 
suggest that systematically offering these interventions to patients with serious and life-
limiting illness has the potential to reduce hospital costs for payers and hospital networks. 
Based on the current literature, our analysis estimates that the savings could entail 11% of all 
ICU costs and 25% of the ICU costs for patients with chronic, life-limiting illness, or age 
over 80 years, who utilize the ICU. These results would extrapolate to potential national 
savings of $8.8 billion over 1 year. Future studies are needed to investigate the optimal 
structure for integrating ACP and palliative care interventions into routine practice and the 
associated costs of these programs.
 Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
Trajectory of patient care during 12 months following index hospitalization. Patients 
experienced a combination of acute care floor and ICU admissions. Gray boxes indicate 
potential points of intervention.
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Figure 2. 
Cost-savings as a result of varying the efficacy of the interventions. For a given % reduction 
in ICU length of stay and a given % reduction in ICU admissions relevant to palliative care 
consultation and ACP, respectively, the intersection point estimates cost-savings per patient. 
Dotted line: base-case efficacy (37% for ACP and 26% for palliative care consultation), 
intersection point represented by dot = $2800 saved per patient; Triangle = cost-savings 
when palliative care is not effective and Square = cost-savings when ACP not effective; 
Panel A: Sample of patients utilizing the ICU in 12 month time-horizon; Panel B: Savings 
spread across entire sample of 2,097,563 patients meeting inclusion criteria in Premier 
database.
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Figure 3. 
Cost-savings as a result of varying efficacy of interventions in survivors. Dotted line: base-
case efficacy of 1/3 as effective in survivors as decedents. Arrows indicate direction for more 
or less efficacy in survivors. Panel A: Sample of patients utilizing the ICU in 12 month time-
horizon; Panel B: Entire sample of 2,097,563 patients meeting inclusion criteria in Premier 
database.
Khandelwal et al. Page 14
Crit Care Med. Author manuscript; available in PMC 2017 August 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Khandelwal et al. Page 15
Table 1
Inclusion criteria
Criteriaa N (%)
Advanced Cancerb 161,677 (7.7)
Congestive Heart Failureb 299,400 (14.3)
Advanced Liver Diseaseb 53,791 (2.6)
COPDb 393,310 (18.8)
Strokeb 386,216 (18.4)
Advanced Dementiab 158,142 (7.5)
ICU admission following stay in hospital regular ward for ≥ 10 days 39,197 (1.9)
Age ≥ 80 AND ≥ 2 life-threatening comorbiditiesc 655,620 (31.3)
Patient suffered a cardiac arrest 95,164 (4.5)
Diagnosis of intracerebral hemorrhage (ICH) requiring mechanical ventilation 2,572 (0.1)
End stage renal disease AND diabetes mellitus 94,825 (4.5)
End stage renal disease AND age ≥ 65 577,803 (27.6)
ICU length of stay ≥ 10 consecutive days 114,703 (5.5)
≥ 2 ICU stays during the same hospitalization 67,922 (3.2)
Age ≥ 80 years old 873,917 (41.7)
aAs reflected in the N (%), these groups are not mutually exclusive. Index admission was considered the first hospital admission in which 1 of these 
criteria were met; patients may meet criteria for multiple categories.
b
In addition to the index admission, patients had 1 additional hospital admission in the preceding 6 months OR 1 ICU admission in the preceding 
12 months with the same diagnosis.
c
Life-threatening comorbidities include: Advanced cancer; Congestive heart failure; Advanced liver disease; COPD; Stroke; Advanced Dementia; 
End Stage Renal Disease
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Table 2
Sample characteristics
Characteristic All Subjects (N=2,097,563) ICU utilizationa (N=657,825) No ICU utilizationa 
(N=1,439,738)
N(%)
Age, mean ± SD 73 ± 14 69 ± 16 74 ± 13
Male Gender 996,808 (47.5) 342,339 (52.0) 654,469 (45.5)
Race
 White 1,427,313 (68.0) 438,237 (66.6) 989,076 (68.7)
 Black 258,875 (12.3) 83,355 (12.7) 175,520 (12.2)
 Hispanic 78,551 (3.7) 24,543 (3.7) 54,008 (3.8)
 Other 332,824 (15.9) 111,690 (17.0) 221,134 (15.4)
Admission type
 Emergency 1,410,908 (67.3) 442,163 (67.2) 968,745 (67.3)
 Urgent 335,965 (16.0) 98,544 (15.0) 237,421 (16.5)
 Elective 333,922 (15.9) 108,165 (16.4) 225,757 (15.7)
 Trauma Center 10,080 (0.5) 6,399 (1.0) 3,681 (0.3)
 Other 6,688 (0.3) 2,554 (0.4) 4,134 (0.3)
In-hospital death 131,528 (6.2) 75,429 (11.5) 56,099 (3.9)
Died in ICU 13,892 (0.7) 13,892 (2.1) N/A
Quan single summary score, mean ± SD 3.39 ± 2.27 3.43 ± 2.34 3.38 ± 2.23
Hospital admissions*, med (IQR) 1 (1,2) 2 (1,3) 1 (1,2)
mean ± SD 2 ± 2 2 ± 2 2 ± 1
Hospital daysa, med (IQR) 10 (5-20) 17 (9-30) 8 (4-15)
  mean ± SD 16 ± 18 24 ± 23 12 ± 13
ICU admissionsa, med (IQR) 0 (0- 1) 1 (1- 2) N/A
  mean ± SD 0 ± 1 1 ± 1 N/A
ICU daysa, med (IQR) 0 (0- 1) 4 (2- 9) N/A
  mean ± SD 2 ± 6 7 ± 10 N/A
Inpatient costsa, med (IQR) 15.6 (7.3,33.7) 35.2 (17.9,64.4) 11.2 (5.8,21.6)
  mean ± SD 28.3 ± 41.1 51.3 ± 58.5 17.8 ±23.3
ICU costsa, med (IQR) 0 (0, 1.9) 5.4 (2.3,13.4) N/A
  mean ± SD 3.5 ± 11.2 11.3 ± 17.6 N/A
At least one intensive therapy dayb 313,239 (14.9) 313,239 (47.6) N/A
   median (IQR) c 2 (1, 4) 2 (1, 4) N/A
  mean ± SDc 4.7 ± 9.5 4.7 ± 9.5 N/A
a
In 12 months following index hospitalization
b
Intensive therapies include mechanical ventilation, renal replacement therapy and/or artificial nutrition
cAmong subjects with at least one intensive therapy day
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